Applications, hearings, determinations, etc.: Medeva Pharmaceuticals CA, Inc.,

[Federal Register: February 4, 1999 (Volume 64, Number 23)]

[Notices]

[Page 5678]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr04fe99-88]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 29, 1998, Medeva Pharmaceuticals CA, Inc., 3501 West Gary Avenue, Santa Ana, California 92704, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of amphetamine (1100), a basic class of controlled substance listed in Schedule II.

The firm plans to synthesize amphetamine to support reintroduction of a product.

Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than (60 days from publication).

Dated: January 27, 1999. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 99-2682Filed2-3-99; 8:45 am]

BILLING CODE 4410-09-M